Single-Cell Omics Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Single-Cell Omics Market Growth Potential: How Will Market Size Change Through 2030?
The single-cell omics market has seen swift expansion in recent years, with projections showing an increase from $2.39 billion in 2025 to $2.78 billion in 2026, representing a compound annual growth rate (CAGR) of 16.3%. This historic period’s growth was driven by progress in next-generation sequencing, a rise in academic research funding, expanding cancer research programs, a need for analyzing cellular heterogeneity, and enhanced cell isolation methods.
The market for single-cell omics is forecast to experience substantial expansion in the coming years. By 2030, its value is projected to reach $5.27 billion, driven by a compound annual growth rate (CAGR) of 17.4%. This anticipated growth during the forecast period is fueled by the broader implementation of precision medicine initiatives, the incorporation of artificial intelligence into omics data interpretation, heightened pharmaceutical research and development spending, greater utilization in clinical diagnostic settings, and the creation of more affordable single-cell platforms. Key emerging trends shaping this period involve a higher uptake of multi-omics strategies, an increased need for fine-scale cellular analysis, a broadening use of single-cell techniques in cancer research, wider application of microfluidic technology for cell separation, and the establishment of standardized protocols for single-cell analytical processes.
Download A Free Sample Report For Comprehensive Market Insights:
Single-Cell Omics Market Expansion Supported By Key Demand Factors
The anticipated increase in cancer cases is set to drive expansion within the single-cell omics market. Cancer encompasses a range of diseases capable of developing in virtually any body tissue or organ, characterized by the uncontrolled growth of abnormal cells that breach normal boundaries, invade adjacent structures, or metastasize to distant sites. Single-cell omics data has been extensively employed to identify biomarkers for cancer diagnosis, predict prognosis, and uncover new therapeutic targets within defined clinical groups. For example, in May 2024, the National Institutes of Health, a US government agency, reported that approximately 18.1 million people in the United States were cancer survivors as of January 2022, with projections indicating this number will climb to 22.5 million by 2032. Consequently, the growing incidence of cancer is fueling momentum in the single-cell omics market.
Single-Cell Omics Market Segment Analysis Highlighting Growth Areas
The single-cell omics market covered in this report is segmented –
1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits
2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits
3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits
4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits
Single-Cell Omics Market Growth Trends Influencing Competitive Dynamics
Leading players in the single-cell omics sector are prioritizing the creation of sophisticated kits—including those designed for sequencing—to support single-cell workflows and boost their market earnings. These sequencing kits consist of pre-assembled reagent and material packages tailored for genetic sequencing tasks, which help simplify lab processes. A notable example occurred in February 2023, when Singular Genomics Systems, Inc., a U.S. firm specializing in innovative next-generation sequencing (NGS), introduced the Max Read Kits for single-cell sequencing on the G4 Sequencing Platform. Engineered to work seamlessly with widely used 10x Genomics assays, these kits offer the flexibility to sequence between 4 and 16 samples per run. Each flow cell delivers 800 million reads, with quality scores ranging from 80% to 90% Q30. Additionally, Singular Genomics has improved the performance standards of the G4 Sequencing Platform’s F2 and F3 flow cells, enabling up to 1.8 billion reads per run on the F3 flow cells for certain applications.
Single-Cell Omics Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries
Access The Complete Single-Cell Omics Market Report:
Single-Cell Omics Market Geographic Distribution And Regional Opportunities
North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
